Enhancing capillary blood collection: The influence of nicotinic acid and nonivamide
- PMID: 28102549
- PMCID: PMC6817299
- DOI: 10.1002/jcla.22142
Enhancing capillary blood collection: The influence of nicotinic acid and nonivamide
Abstract
Background: Nicotinic acid and nonivamide are often applied topically during capillary blood collection to induce vasodilation. These molecules may have an influence on immune effector cell activity in nearby tissues. This study investigates whether the induction of flushing by nicotinic acid and nonivamide causes an inflammatory response that influences the composition of immune cells present in a capillary blood sample.
Methods: Females aged between 18 and 30 years old provided capillary blood samples. Experimental samples were taken from an earlobe treated with nicotinic acid and nonivamide with controls obtained from the untreated earlobe. Immunophenotypic analyses were conducted using polychromatic flow cytometry to determine whether any changes occurred in leucocyte subpopulations (CD3, CD4, CD8, CD19, CD56, and CD14) and granulocytic functional-related surface antigen markers (CD11b, CD18, CD16b, and CD66b).
Results: No significant differences were observed between experimental and control samples in the mean percent of parent for the lymphocyte, monocyte, or granulocyte subpopulations, or in the median fluorescence intensity of particular surface markers expressed on these leucocytes.
Conclusion: The topical application of nicotinic acid and nonivamide is a possible method to improve capillary blood collection for immunological assessments. The use of these agents may increase the safety and compliance of patients who suffer from needle phobia or are unable to provide venous blood samples.
Keywords: B cells; Finalgon; T cells; Venous Blood; blood testing; capillary blood; flow cytometry; leukocytes; nicotinic acid; nonivamide.
© 2017 Wiley Periodicals, Inc.
Similar articles
-
Comparison of capillary and venous blood in the analysis of concentration and function of leucocyte sub-populations.Eur J Appl Physiol. 2016 Aug;116(8):1583-93. doi: 10.1007/s00421-016-3413-z. Epub 2016 Jun 15. Eur J Appl Physiol. 2016. PMID: 27306382
-
Cardiovascular effects of nonivamide succinate.Gaoxiong Yi Xue Ke Xue Za Zhi. 1991 Apr;7(4):173-82. Gaoxiong Yi Xue Ke Xue Za Zhi. 1991. PMID: 2030524
-
Evaluation of changes in the haemoglobin of skin and muscle tissue of the calf, as induced by topical application of a nonivamide/nicoboxil cream.Can J Physiol Pharmacol. 2014 Feb;92(2):149-54. doi: 10.1139/cjpp-2013-0158. Epub 2013 Oct 21. Can J Physiol Pharmacol. 2014. PMID: 24502638
-
Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials.Trends Pharmacol Sci. 2011 Dec;32(12):700-7. doi: 10.1016/j.tips.2011.08.002. Epub 2011 Sep 22. Trends Pharmacol Sci. 2011. PMID: 21944259 Review.
-
[Deep lung--cellular reaction to HIV].Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Rev Port Pneumol. 2007. PMID: 17492233 Review. Portuguese.
Cited by
-
The identification of diurnal variations on circulating immune cells by finger prick blood sampling in small sample sizes: a pilot study.Lab Med. 2024 Mar 7;55(2):220-226. doi: 10.1093/labmed/lmad062. Lab Med. 2024. PMID: 37478465 Free PMC article.
References
-
- Abbott . Clinical Evaluation of a Faster, Smaller Sample Volume Blood ß‐Ketone Test Strip. Alameda, CA: Abbott Diabetes Care Inc.; 2006.
-
- Boehringer Ingelheim . North Ryde, NSW: Finalgon Cream Consumer Medicine Information. 2010. Available from: http://files.boehringer.com.au/files/CMI/Finalgon%20CMI.pdf, Accessed December 9, 2016.
-
- Schneider AJ, Miller R, Baetz WR. Improved ear oximetry with a rubefacient ointment. Crit Care Med. 1978;6:384–386. - PubMed
-
- Sauve AA. NAD+ and vitamin B3: from metabolism to therapies. J Pharmacol Exp Ther. 2008;324:883–893. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials